1.Approaching trauma analgesia using prolonged and novel continuous peripheral nerve blocks - A case report -
Eric LY ; Sai VELAMURI ; William HICKERSON ; David M. HILL ; Jay DESAI ; Ban TSUI ; Michael HERR ; Jerry JONES
Anesthesia and Pain Medicine 2022;17(1):87-92
A supraclavicular brachial plexus nerve block provides analgesia for the shoulder, arm, and hand; however, the maximum safe duration for a continuous infusion remains controversial. A novel continuous peripheral nerve block (CPNB) technique combining the Lateral, Intermediate, and Medial femoral cutaneous nerves (termed the ‘LIM’ block) to provide analgesia to the lateral, anterior, and medial cutaneous areas of the thigh while preserving quadriceps strength will also be described in detail here. Case: We present a complex case in which simultaneous utilization of an unilateral supraclavicular CPNB (5 weeks) and bilateral LIM CPNB (5 days) are successfully performed to provide analgesia for a traumatic degloving injury resulting in multiple surgeries. Conclusions: The analgesic plan in this case study eliminated previous episodes of opioid-induced delirium, facilitated participation in recovery, and removed concerns for respiratory depression and chronic opioid use in a patient at particular risk for both issues.
2.Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21International Symposium on Microsomes and Drug Oxidations (MDO).
Ai-Ming YU ; Magnus INGELMAN-SUNDBERG ; Nathan J CHERRINGTON ; Lauren M ALEKSUNES ; Ulrich M ZANGER ; Wen XIE ; Hyunyoung JEONG ; Edward T MORGAN ; Peter J TURNBAUGH ; Curtis D KLAASSEN ; Aadra P BHATT ; Matthew R REDINBO ; Pengying HAO ; David J WAXMAN ; Li WANG ; Xiao-Bo ZHONG
Acta Pharmaceutica Sinica B 2017;7(2):241-248
Variations in drug metabolism may alter drug efficacy and cause toxicity; better understanding of the mechanisms and risks shall help to practice precision medicine. At the 21International Symposium on Microsomes and Drug Oxidations held in Davis, California, USA, in October 2-6, 2016, a number of speakers reported some new findings and ongoing studies on the regulation mechanisms behind variable drug metabolism and toxicity, and discussed potential implications to personalized medications. A considerably insightful overview was provided on genetic and epigenetic regulation of gene expression involved in drug absorption, distribution, metabolism, and excretion (ADME) and drug response. Altered drug metabolism and disposition as well as molecular mechanisms among diseased and special populations were presented. In addition, the roles of gut microbiota in drug metabolism and toxicology as well as long non-coding RNAs in liver functions and diseases were discussed. These findings may offer new insights into improved understanding of ADME regulatory mechanisms and advance drug metabolism research.